Literature DB >> 32634827

Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)-A Danish Nationwide, Register-based Study.

Kristian Kragholm1,2,3, Mikkel Porsborg Andersen4, Thomas A Gerds5, Jawad H Butt6, Lauge Østergaard6, Christoffer Polcwiartek3, Matthew Phelps7, Charlotte Andersson8, Gunnar H Gislason7,8, Christian Torp-Pedersen3,4, Lars Køber6, Morten Schou8, Emil L Fosbøl6.   

Abstract

BACKGROUND AND OBJECTIVES: Male sex has been associated with severe coronavirus disease 2019 (COVID-19) infection. We examined the association between male sex and severe COVID-19 infection and if an increased risk remains after adjustment for age and comorbidities.
METHODS: Nationwide register-based follow-up study of COVID-19 patients in Denmark until 16 May 2020. Average risk ratio comparing 30-day composite outcome of all-cause death, severe COVID-19 diagnosis or intensive care unit (ICU) admission for men versus women standardized to the age and comorbidity distribution of all patients were derived from multivariable Cox regression. Included covariates were age, hypertension, diagnoses including obesity, alcohol, sleep apnea, diabetes, chronic obstructive pulmonary disease, previous myocardial infarction (MI), ischemic heart disease (IHD), heart failure (HF), atrial fibrillation (AF), stroke, peripheral artery disease, cancer, liver, rheumatic, and chronic kidney disease (CKD).
RESULTS: Of 4842 COVID-19 patients, 2281 (47.1%) were men. Median age was 57 [25%-75% 43-73] for men versus 52 [38-71] for women (P < .001); however, octogenarians had equal sex distribution. Alcohol diagnosis, diabetes, hypertension, sleep apnea, prior MI and IHD (all P < .001) as well as AF, stroke, and HF (all P = .01) were more often seen in men, and so was CKD (P = .03). Obesity diagnosis (P < .001) were more often seen in women. Other comorbidity differences were insignificant (P > .05). The fully adjusted average risk ratio was 1.63 [95% CI, 1.44-1.84].
CONCLUSIONS: Men with COVID-19 infection have >50% higher risk of all-cause death, severe COVID-19 infection, or ICU admission than women. The excess risk was not explained by age and comorbidities.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  sex; COVID-19; outcomes; severity

Mesh:

Year:  2021        PMID: 32634827      PMCID: PMC7454435          DOI: 10.1093/cid/ciaa924

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

1.  Factors Associated for COVID19 Severity Among Patients Treated at Selgalu Treatment Center Assosa in Ethiopia: A Case-Control Study.

Authors:  Dano Gutata; Zewdie Aderaw Alemu
Journal:  Int J Gen Med       Date:  2022-03-24

2.  Using Integrative Behavior Model to Predict COVID-19 Vaccination Intention among Health Care Workers in Indonesia: A Nationwide Survey.

Authors:  Sukamto Koesnoe; Tommy Hariman Siddiq; Dicky C Pelupessy; Evy Yunihastuti; Ghina Shabrina Awanis; Alvina Widhani; Teguh Harjono Karjadi; Suzy Maria; Anshari Saifuddin Hasibuan; Iris Rengganis; Samsuridjal Djauzi
Journal:  Vaccines (Basel)       Date:  2022-05-04

3.  A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.

Authors:  Hyung-Jun Kim; Hyeontaek Hwang; Hyunsook Hong; Jae-Joon Yim; Jinwoo Lee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

4.  Severe mental illness is associated with increased mortality and severe course of COVID-19.

Authors:  Carlo Alberto Barcella; Christoffer Polcwiartek; Grimur Høgnason Mohr; Gethin Hodges; Kathrine Søndergaard; Casper Niels Bang; Mikkel Porsborg Andersen; Emil Fosbøl; Lars Køber; Morten Schou; Christian Torp-Pedersen; Lars Vedel Kessing; Gunnar Gislason; Kristian Kragholm
Journal:  Acta Psychiatr Scand       Date:  2021-05-13       Impact factor: 7.734

5.  Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement.

Authors:  Aditi Bhargava; Arthur P Arnold; Debra A Bangasser; Kate M Denton; Arpana Gupta; Lucinda M Hilliard Krause; Emeran A Mayer; Margaret McCarthy; Walter L Miller; Armin Raznahan; Ragini Verma
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 25.261

6.  Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series.

Authors:  Hareton Teixeira Vechi; Lucas Rodrigues Maia; Manoella do Monte Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-09-04       Impact factor: 1.846

7.  Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy.

Authors:  Valeria Raparelli; Luigi Palmieri; Marco Canevelli; Flavia Pricci; Brigid Unim; Cinzia Lo Noce; Emanuele R Villani; Paula A Rochon; Louise Pilote; Nicola Vanacore; Graziano Onder
Journal:  Biol Sex Differ       Date:  2020-10-16       Impact factor: 5.027

8.  Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients.

Authors:  F A Cadegiani; A Goren; C G Wambier; J McCoy
Journal:  New Microbes New Infect       Date:  2021-07-07

9.  Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease.

Authors:  Muhamed-Kheir Taha; Ala-Eddine Deghmane
Journal:  BMC Res Notes       Date:  2020-08-27

10.  Sex differences in COVID-19 course and outcome: progesterone should not be neglected.

Authors:  Hrvoje Jakovac
Journal:  J Appl Physiol (1985)       Date:  2020-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.